Diocto Liquid Stool Softener Recalled for Microbial Contamination
The Harvard Drug Group is recalling Diocto Liquid stool softener bottles due to positive findings of Burkholderia cepacia contamination.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The source text identifies the agency classification as Class I, which corresponds to a Critical severity score per the rubric.
Plain-English summary
The Harvard Drug Group is voluntarily recalling 153,432 bottles of Diocto Liquid (docusate sodium) 50 mg/5 mL Stool Softener Laxative. The product is distributed in one-pint (473 mL) bottles under NDC 0536-0590-85. The recall is being conducted because of microbial contamination, specifically positive findings of Burkholderia cepacia in non-sterile products.
The affected lots were distributed nationwide. The specific lot codes and expiration dates involved in the recall range from September 2016 to April 2018. Consumers should check their bottles for the specific lot codes and expiration dates listed in the official recall notice to determine if they are affected.
Individuals with the affected product should stop using it and contact the recalling firm for instructions on how to return the product or obtain a refund. The FDA classifies this recall as Class I, indicating a reasonable probability that the use of or exposure to the violative product will cause serious adverse health consequences or death.
The recalled product
- Product
- Diocto Liquid (docusate sodium) 50 mg/5 mL Stool Softener Laxative, One Pint (473 mL) bottles, Dist by: Rugby Laboratories, Livonia, MI --- NDC 0536-0590-85
- Manufacturer
- The Harvard Drug Group
- Category
- Drug — Laxative
- Affected units
- 153,432
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- 20351407
- 20351408
- exp 09/16
- 20351409
- exp 11/16
- 20351410
- exp 12/16
- 20351501
- 20351502
- exp 01/17
- 20351503
- exp 03/17
- 20351504
- exp 04/17
- 20351505
- exp 05/17
- 20351506
- 20351507
- exp 06/17
- 20351508
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · The Harvard Drug Group
See all →- ModerateTramadol Hydrochloride Tablets Recalled Due to Inadequate Blister Packaging Seal
FDA (Drugs) · 2023-07-05
- ModerateGabapentin tablets recalled due to product mixup with foreign tablet
FDA (Drugs) · 2023-05-17
- HighCarbidopa and Levodopa Tablets Recalled for Inadequate Blister Packaging Seal
FDA (Drugs) · 2023-03-08
- ModeratehydrALAZINE HCl Tablets 10 mg Recalled for Failed Impurity Specifications
FDA (Drugs) · 2022-03-23
- ModeratePaliperidone Extended-Release Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-03-16
Same hazard · microbial contamination
See all →- CriticalVictory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination
FDA (Drugs) · 2026-08-19
- HighMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15